Close
  • 00 atmail

Items tagged with: drug discovery

Team Members
    Portfolio Items
    • Mimetica

      Mimetica is a Brisbane-based biotechnology company which has developed a proprietary class of small molecule scaffolds that mimic reverse-turn motifs of peptides. These scaffolds have been used to create novel small molecule mimics of several important peptides and proteins known to be involved in the pathogenesis of disease. Mimetica is currently focusing its initial drug development activities on dermatological applications.

    • MuriGen Therapeutics

      MuriGen Therapeutics is a drug discovery and development company established by the Walter and Eliza Hall Institute of Medical Research (WEHI).

      MuriGen is building a portfolio of novel drugs for unmet medical needs across a number of therapeutic areas including cancer, arthritis, thrombocytopenia, inflammation, epilepsy and thalassemia.

    • Protagonist

      Protagonist is focused on the discovery of drug candidates for targets previously resistant to small molecule discovery (protein-protein interactions) and on designing and constructing arrays of molecules that sample biologically-relevant regions of chemical diversity.

    News Articles